Caryn Lerman
#143,646
Most Influential Person Now
American psychologist
Caryn Lerman's AcademicInfluence.com Rankings
Caryn Lermanpsychology Degrees
Psychology
#3845
World Rank
#4307
Historical Rank
Clinical Psychology
#387
World Rank
#392
Historical Rank
Download Badge
Psychology
Caryn Lerman's Degrees
- Bachelors Psychology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Caryn Lerman Influential?
(Suggest an Edit or Addition)According to Wikipedia, Caryn E. Lerman is an American psychologist. She is the director of the USC Norris Comprehensive Cancer Center through the Keck School of Medicine. Early life and education Lerman completed her Bachelor of Science degree in psychology from Pennsylvania State University in 1981 before moving to California and enrolling in the University of Southern California for her Master's degree and PhD.
Caryn Lerman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genome-wide meta-analyses identify multiple loci associated with smoking behavior (2010) (1107)
- Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation (2006) (280)
- Genetic testing: psychological aspects and implications. (2002) (261)
- Neural Substrates of Abstinence-Induced Cigarette Cravings in Chronic Smokers (2007) (242)
- Molecular genetics of successful smoking cessation: convergent genome-wide association study results. (2008) (235)
- Cigarette Smoking Practices Among American College Students: Review and Future Directions (2004) (228)
- Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. (2015) (222)
- Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: A validation study (2009) (215)
- Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain (2003) (214)
- Varenicline Improves Mood and Cognition During Smoking Abstinence (2009) (206)
- Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function. (2014) (191)
- Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy (2006) (190)
- Role of Functional Genetic Variation in the Dopamine D2 Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials (2006) (186)
- The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial (2004) (185)
- Toward Personalized Therapy for Smoking Cessation: A Randomized Placebo‐controlled Trial of Bupropion (2008) (183)
- Prevention of cancer in the next millennium: Report of the Chemoprevention Working Group to the American Association for Cancer Research. (1999) (178)
- Working memory deficits predict short-term smoking resumption following brief abstinence. (2010) (176)
- Pharmacogenetic investigation of smoking cessation treatment. (2002) (172)
- Narrative Health Communication and Behavior Change: The Influence of Exemplars in the News on Intention to Quit Smoking. (2012) (172)
- A Measure of Perceived Argument Strength: Reliability and Validity (2011) (166)
- Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior (2009) (164)
- Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. (2003) (159)
- Translational research in medication development for nicotine dependence (2007) (149)
- Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). (2008) (146)
- Nicotinic acetylcholine receptor β2 subunit gene implicated in a systems-based candidate gene study of smoking cessation (2008) (141)
- Mediating mechanisms for the impact of bupropion in smoking cessation treatment. (2002) (140)
- Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures. (2007) (140)
- Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment (2014) (137)
- Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers (2011) (136)
- CYP2B6 Genotype Alters Abstinence Rates in a Bupropion Smoking Cessation Trial (2007) (134)
- Association of OPRM1 A118G variant with the relative reinforcing value of nicotine (2006) (127)
- Elucidating the role of genetic factors in smoking behavior and nicotine dependence (2003) (127)
- Nicotine Dependence Pharmacogenetics: Role of Genetic Variation in Nicotine-Metabolizing Enzymes (2009) (125)
- CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. (2007) (124)
- Relationship between education and delay discounting in smokers. (2004) (124)
- New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure. (2007) (124)
- Interacting effects of genetic predisposition and depression on adolescent smoking progression. (2004) (121)
- Comparison between two measures of delay discounting in smokers. (2003) (116)
- Current and emerging pharmacotherapies for treating tobacco dependence (2006) (115)
- Effects of the α4β2 Partial Agonist Varenicline on Brain Activity and Working Memory in Abstinent Smokers (2010) (113)
- Genetic Variation in Nicotine Metabolism Predicts the Efficacy of Extended‐Duration Transdermal Nicotine Therapy (2010) (111)
- Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials (2011) (110)
- Food hedonics and reinforcement as determinants of laboratory food intake in smokers (2004) (107)
- Nicotine Metabolite Ratio Predicts Smoking Topography and Carcinogen Biomarker Level (2011) (105)
- Individual differences in nicotine intake per cigarette. (2003) (103)
- Reduced prefrontal and temporal processing and recall of high “sensation value” ads (2009) (103)
- Influence of methylphenidate on eating in obese men. (2004) (102)
- Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. (2004) (101)
- Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients (2004) (98)
- An association of CYP2A6 genotype and smoking topography. (2007) (96)
- Known and Novel Sources of Variability in the Nicotine Metabolite Ratio in a Large Sample of Treatment-Seeking Smokers (2014) (96)
- Medication screening for smoking cessation: a proposal for new methodologies (2006) (95)
- Initial nicotine sensitivity in humans as a function of impulsivity (2008) (95)
- Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood (2008) (94)
- Nicotinic acetylcholine receptor variation and response to smoking cessation therapies (2013) (93)
- Working Memory-Related Neural Activity Predicts Future Smoking Relapse (2015) (91)
- Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. (2007) (90)
- Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women (2005) (90)
- Treating tobacco dependence: state of the science and new directions. (2005) (90)
- Effectiveness of Extended-Duration Transdermal Nicotine Therapy (2010) (89)
- Applying genetic approaches to the treatment of nicotine dependence (2002) (88)
- Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype (2009) (88)
- Catechol-O-Methyltransferase (COMT) Gene Variants Predict Response to Bupropion Therapy for Tobacco Dependence (2007) (88)
- Treating tobacco dependence in women. (2007) (87)
- Genetic testing for cancer susceptibility: the promise and the pitfalls (2004) (84)
- Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. (2001) (83)
- Content Matters: Neuroimaging Investigation of Brain and Behavioral Impact of Televised Anti-Tobacco Public Service Announcements (2013) (83)
- Pharmacotherapy and pharmacogenetics of nicotine dependence. (2005) (82)
- Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers (2005) (80)
- Genetics and smoking cessation improving outcomes in smokers at risk. (2007) (80)
- No Effect of Commercial Cognitive Training on Brain Activity, Choice Behavior, or Cognitive Performance (2017) (79)
- The Ability of Plasma Cotinine to Predict Nicotine and Carcinogen Exposure is Altered by Differences in CYP2A6: the Influence of Genetics, Race, and Sex (2013) (79)
- Reduced nicotine reward in obesity: cross-comparison in human and mouse (2005) (78)
- Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. (2005) (76)
- Effect of bupropion on depression symptoms in a smoking cessation clinical trial. (2004) (72)
- Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. (2007) (72)
- A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patients (2005) (70)
- Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial (2004) (70)
- Facilitating transdisciplinary research: the experience of the transdisciplinary tobacco use research centers. (2003) (70)
- Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. (2004) (69)
- Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm (2005) (66)
- Development of Procedures for Early Screening of Smoking Cessation Medications in Humans (2008) (66)
- Barriers to translating emerging genetic research on smoking into clinical practice (2005) (66)
- Balancing Consideration of the Risks and Benefits of E-Cigarettes. (2021) (65)
- Smoking topography predicts abstinence following treatment with nicotine replacement therapy. (2004) (65)
- Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation (2015) (65)
- Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms (2004) (64)
- Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice. (2008) (63)
- Pharmacogenetics and nicotine addiction treatment. (2005) (63)
- Changes in food reward following smoking cessation: a pharmacogenetic investigation (2004) (63)
- Facilitating clinical implementation of pharmacogenomics. (2011) (62)
- Transcranial direct current brain stimulation decreases impulsivity in ADHD (2018) (62)
- The effect of smoking cues in antismoking advertisements on smoking urge and psychophysiological reactions. (2009) (61)
- Experimental evaluation of antitobacco PSAs: effects of message content and format on physiological and behavioral outcomes. (2009) (60)
- Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio (2016) (57)
- Biomarkers for Smoking Cessation (2013) (57)
- Nicotine dependence: biology, behavior, and treatment. (2009) (57)
- Lack of Association of 5-HTTLPR Genotype with Smoking Cessation in a Nicotine Replacement Therapy Randomized Trial (2006) (57)
- Genetics and smoking behavior (2007) (57)
- Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users. (2009) (57)
- Smoking in response to negative mood in men versus women as a function of distress tolerance. (2012) (55)
- Using logistic regression to estimate delay-discounting functions (2004) (54)
- Transcranial Direct Current Brain Stimulation Increases Ability to Resist Smoking (2016) (53)
- Individualizing Nicotine Replacement Therapy for the Treatment of Tobacco Dependence (2004) (52)
- Dopamine transporter genotype as a risk factor for obesity in African-American smokers. (2002) (51)
- Amygdala Functional and Structural Connectivity Predicts Individual Risk Tolerance (2018) (51)
- Dopamine Transporter Binding in Smokers and Nonsmokers (2007) (50)
- Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollment (2004) (50)
- Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials (2005) (49)
- Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking (2016) (48)
- Translating emerging research on the genetics of smoking into clinical practice: ethical and social considerations. (2004) (48)
- Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers (2008) (48)
- Smoking cues, argument strength, and perceived effectiveness of antismoking PSAs. (2011) (47)
- Associations between Cloninger's temperament dimensions and acute tobacco withdrawal. (2007) (47)
- CYP2B6 Genotype Does Not Alter Nicotine Metabolism, Plasma Levels, or Abstinence with Nicotine Replacement Therapy (2007) (47)
- Dopamine genes and nicotine dependence in treatment seeking and community smokers (2009) (46)
- Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence (2006) (46)
- Cross‐Validation of a New Procedure for Early Screening of Smoking Cessation Medications in Humans (2010) (46)
- Anticipating Clinical Integration of Pharmacogenetic Treatment Strategies for Addiction: Are Primary Care Physicians Ready? (2008) (45)
- Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion. (2005) (45)
- Identification of pharmacogenetic markers in smoking cessation therapy (2008) (44)
- Nicotine abstinence-induced cerebral blood flow changes by genotype (2008) (43)
- Increase in anger symptoms after smoking cessation predicts relapse. (2008) (43)
- Age‐related differences in working memory deficits during nicotine withdrawal (2014) (42)
- Leadership Development in Medicine. (2018) (42)
- Nicotinic Acetylcholine Receptor β2 Subunit (CHRNB2) Gene and Short-Term Ability to Quit Smoking in Response to Nicotine Patch (2009) (41)
- Convergent Evidence that Choline Acetyltransferase Gene Variation is Associated with Prospective Smoking Cessation and Nicotine Dependence (2010) (41)
- Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes (2012) (40)
- Variability in initial nicotine sensitivity due to sex, history of other drug use, and parental smoking. (2009) (39)
- Intergenerational transmission of tobacco use and dependence: a transdisciplinary perspective. (2003) (39)
- Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. (2013) (39)
- Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial. (2007) (39)
- Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking (2015) (38)
- Genetics and Drug Use as a Complex Phenotype (2004) (38)
- Evidence from Mouse and Man for a Role of Neuregulin 3 in Nicotine Dependence (2013) (38)
- Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment (2008) (36)
- Frontiers in cancer prevention research. (2003) (35)
- Do small lapses predict relapse to smoking behavior under bupropion treatment? (2004) (35)
- Genome‐wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences (2018) (35)
- Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counseling. (2003) (34)
- Effects of smoking cues and argument strength of antismoking advertisements on former smokers' self-efficacy, attitude, and intention to refrain from smoking. (2013) (34)
- A placebo-controlled trial of modafinil for nicotine dependence. (2008) (34)
- An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation (2013) (33)
- Supplementing High-Density SNP Microarrays for Additional Coverage of Disease-Related Genes: Addiction as a Paradigm (2009) (32)
- Non-replication of genetic association studies: is DAT all, folks? (2002) (32)
- Evaluating smokers' reactions to advertising for new lower nicotine quest cigarettes. (2006) (30)
- Effects of different nicotine replacement therapies on postcessation psychological responses. (2004) (30)
- Genomics of Smoking Exposure and Cessation: Lessons for Cancer Prevention and Treatment (2008) (30)
- Neuroimaging, genetics and the treatment of nicotine addiction (2008) (30)
- Brain Responses to Smoking Cues Differ Based on Nicotine Metabolism Rate (2016) (29)
- Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses. (2008) (28)
- Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers. (2011) (28)
- Which Adolescents Are Most Receptive to Tobacco Industry Marketing? Implications for Counter-Advertising Campaigns (2003) (28)
- Catechol-O-Methyl-Transferase Functional Polymorphism and Nicotine Dependence: an Evaluation of Nonreplicated Results (2005) (28)
- Genome-wide association meta-analysis of nicotine metabolism and cigarette consumption measures in smokers of European descent (2020) (28)
- RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and alleles (2015) (27)
- Pharmacogenetic Association of the Galanin Receptor (GALR1) SNP rs2717162 with Smoking Cessation (2012) (26)
- Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism (2015) (26)
- Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers. (2004) (26)
- Evaluating the Temporal Relationships Between Withdrawal Symptoms and Smoking Relapse (2019) (26)
- Applying Quantitative Approaches to the Formative Evaluation of Antismoking Campaign Messages (2013) (26)
- Reinforcing Effects of Smoking: More Than a Feeling (2010) (25)
- Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation. (2008) (25)
- Severity of tobacco abstinence symptoms varies by time of day. (2009) (25)
- Comparative dynamics of four smoking withdrawal symptom scales. (2012) (24)
- A systems biology network model for genetic association studies of nicotine addiction and treatment (2009) (24)
- Differences in the rate of nicotine metabolism among smokers with and without HIV. (2019) (23)
- The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio. (2016) (23)
- Enhanced identification of smoking-related words during the attentional blink in smokers. (2007) (23)
- Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence (2009) (22)
- Primary care physicians' willingness to offer a new genetic test to tailor smoking treatment, according to test characteristics. (2008) (22)
- Varenicline’s effects on acute smoking behavior and reward and their association with subsequent abstinence (2010) (22)
- Effects of bupropion on cognitive performance during initial tobacco abstinence. (2013) (22)
- Measures and predictors of varenicline adherence in the treatment of nicotine dependence. (2017) (21)
- Nicotine Receptor Subtype-Specific Effects on Auditory Evoked Oscillations and Potentials (2012) (21)
- News about Genetics and Smoking (2005) (20)
- Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation. (2012) (20)
- Brain activity and emotional processing in smokers treated with varenicline (2013) (20)
- Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study. (2012) (20)
- Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption (2015) (20)
- Association of retrospective early smoking experiences with prospective sensitivity to nicotine via nasal spray in nonsmokers. (2008) (19)
- Transdisciplinary science applied to the evaluation of treatments for tobacco use. (2003) (19)
- Nicotine withdrawal alters neural responses to psychosocial stress (2016) (19)
- Neuroimaging in Psychiatric Pharmacogenetics Research: The Promise and Pitfalls (2013) (19)
- Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment? (2017) (19)
- Smoking cessation treatment: pharmacogenetic assessment. (2005) (19)
- Priming, Family Smoking History, and News Story Believability on Inferences of Genetic Susceptibility to Tobacco Addiction (2005) (18)
- Neural cue reactivity during acute abstinence predicts short‐term smoking relapse (2020) (18)
- Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications. (2013) (18)
- No untoward effects of smoking cues in anti-smoking public service announcements. (2013) (18)
- Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence. (2015) (17)
- Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers. (2015) (17)
- Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial. (2016) (17)
- Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity (2020) (17)
- Subjective effects of an initial dose of nicotine nasal spray predict treatment outcome (2004) (17)
- The DRD4 exon III VNTR, bupropion, and associations with prospective abstinence. (2013) (16)
- Gender Stratified Gene and Gene–Treatment Interactions in Smoking Cessation (2011) (16)
- Nicotine vaccines: will smokers take a shot at quitting? (2010) (16)
- Replication and extension of association of choline acetyltransferase with nicotine dependence in European and African American smokers (2010) (16)
- Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism (2018) (16)
- Can brain games help smokers quit?: Results of a randomized clinical trial. (2016) (16)
- Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study. (2013) (16)
- Ethical issues in conducting behavioral genetics research: the case of smoking prevention trials among adolescents. (2002) (16)
- The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions (2020) (15)
- Mouse model predicts effects of smoking and varenicline on event-related potentials in humans. (2010) (15)
- Association of Reduced Nicotine Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow and Fast Nicotine Metabolizers (2018) (15)
- Association of abstinence-induced alterations in working memory function and COMT genotype in smokers (2013) (15)
- The public health utility of genome-wide association study results for smoking behavior (2010) (13)
- A Novel Recruitment Message to Increase Enrollment Into a Smoking Cessation Treatment Program: Preliminary Results From a Randomized Trial (2011) (13)
- The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy. (2011) (12)
- Early Human Screening of Medications to Treat Drug Addiction: Novel Paradigms and the Relevance of Pharmacogenetics (2011) (12)
- Pharmacogenetics and Smoking Cessation with Nicotine Replacement Therapy (2007) (12)
- Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome. (2014) (12)
- Chapter 13 – Smoking Behavior and Smoking Cessation among Head and Neck Cancer Patients (2003) (12)
- No Evidence for a Major Role of Polymorphisms During Bupropion Treatment (2006) (11)
- Lack of effect of transcranial direct current stimulation (tDCS) on short-term smoking cessation: Results of a randomized, sham-controlled clinical trial. (2019) (11)
- Differences in Young Adults’ Perceptions of and Willingness to Use Nicotine Pouches by Tobacco Use Status (2022) (10)
- Toward Precision Medicine for Smoking Cessation: Developing a Neuroimaging-Based Classification Algorithm to Identify Smokers at Higher Risk for Relapse. (2019) (10)
- A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine (2018) (10)
- Nicotine normalizes event related potentials in COMT-Val-tg mice and increases gamma and theta spectral density. (2012) (10)
- Genetic Basis of Substance Use and Dependence: Implications for Prevention in High-Risk Youth (2003) (10)
- Helping smokers quit through pharmacogenetics. (2006) (9)
- Transferability of Ancestry‐Specific and Cross‐Ancestry CYP2A6 Activity Genetic Risk Scores in African and European Populations (2020) (9)
- Translating basic science to improve pharmacotherapy for nicotine dependence. (2007) (9)
- DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers (2012) (9)
- μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief (2012) (9)
- Association of BDNF and COMT genotypes with cognitive processing of anti‐smoking PSAs (2011) (9)
- Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes. (2019) (9)
- Cancer Epidemiology, Biomarkers & Prevention, and Cancer Prevention Research: Two Journals, a Common Goal (2008) (9)
- Impact of Early Nausea on Varenicline Adherence and Smoking Cessation. (2019) (8)
- CREB1 haplotypes and the relative reinforcing value of nicotine (2007) (8)
- Got chocolate? Bilateral prefrontal cortex stimulation augments chocolate consumption (2018) (8)
- Dosimetry of 11C-carfentanil, a μ-opioid receptor imaging agent (2009) (7)
- Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes. (2018) (7)
- Differences in the rate of nicotine metabolism among smokers with and without HIV. (2019) (7)
- Brain Marker Links Stress and Nicotine Abstinence. (2020) (6)
- Behavioral oncology and the war on cancer: partnering with biomedicine. (2009) (6)
- APOE ε4, an Alzheimer’s disease susceptibility allele, and smoking cessation (2012) (6)
- Translational medication development for nicotine addiction. (2010) (5)
- Spiral computed tomography and lung cancer: science, the media, and public opinion. (2007) (5)
- Familial Risk Cues in Direct-to-Consumer Prescription Drug Advertisements: Impacts on Intentions to Adopt Healthy Lifestyles and Pharmaceutical Choices (2010) (5)
- Can pharmacogenetics help smokers quit? (2006) (5)
- Nicotine metabolite ratio: Comparison of the three urinary versions to the plasma version and nicotine clearance in three clinical studies. (2021) (4)
- Nicotine Dependence and Pharmacogenetics (2010) (4)
- The Integration of Research from Diverse Fields: Transdisciplinary Approaches Bridging Behavioral Research, Cognitive Neuroscience, Pharmacology, and Genetics to Reduce Cancer Risk Behavior (2019) (4)
- What a medical school chair wants from the dean (2018) (4)
- Functional characterization of novel rare CYP2A6 variants and potential implications for clinical outcomes (2021) (4)
- Transdisciplinary Tobacco Use Research Centers: research achievements and future implications. (2009) (4)
- Translational Research on Nicotine Dependence. (2016) (4)
- Analyses of nicotine metabolism biomarker genetics stratified by sex in African and European Americans (2021) (4)
- Improvement of the association between self-reported pill count and varenicline levels following exclusion of participants with misreported pill count: A commentary on Peng et al. (2017). (2018) (4)
- Genetic Information in News:Deterministic and Probabilistic Frames About Genetic Susceptibilities to Smoking Addiction and Disease (2006) (3)
- Patterns of lapses and recoveries during a quit attempt using varenicline and behavioral counseling among smokers with and without HIV. (2020) (3)
- Null Results in Brief CYP 2 B 6 Genotype Does Not Alter Nicotine Metabolism , Plasma Levels , or Abstinence with Nicotine Replacement Therapy (2007) (2)
- Preclinical Data Elucidate Molecular and Neural Mechanisms of Perinatal Nicotine Effects on Neurodevelopment and Behavior: Translational Opportunities and Implications (2010) (2)
- Young adults' beliefs about modern oral nicotine products: Implications for uptake in nonvapers, dual use with e-cigarettes, and use to reduce/quit vaping. (2022) (2)
- Improving Antismoking Message Effectiveness: Death Appeals, Argument Strength, and Message Sensation Value (2008) (2)
- Whole body dosimetry of [11C] carfentanil: A {micro}-opioid receptor imaging agent (2009) (2)
- Pharmacogenetic approaches to the treatment of nicotine dependence (2006) (2)
- Short communication Mediating mechanisms for the impact of bupropion in smoking cessation treatment (2002) (2)
- Augmenting machine learning algorithms to predict mortality using patient-reported outcomes in oncology. (2021) (1)
- Lower nicotine cigarettes may not lower harm. (2006) (1)
- Nicotine Dependence: Current Treatments and Future Directions (2008) (1)
- Genes, smoking, and treatment response. (2003) (1)
- Evaluation of nicotine patch adherence measurement using self-report and saliva cotinine among abstainers in a smoking cessation trial. (2020) (1)
- A genome-wide association study of nausea incidence in varenicline-treated cigarette smokers. (2021) (1)
- Genetic Cues in Direct-to-Consumer Prescription Drug Advertisements: Impact on Inferences of Genetic Susceptibility to Health Conditions, Self-Efficacy, and Behavioral Intentions (2007) (1)
- P13. Dissecting the Association of CYP2A6 With Nicotine Metabolism in African American Smokers (2022) (0)
- A new chapter in the history of SRNT: the formation of the European chapter of SRNT (SRNT-E)--a letter from the Presidents of SRNT and SRNT Europe. (2010) (0)
- Intention to Abstain From Smoking Measure (2014) (0)
- Nicotine dependence treatment: A translational research approach (2009) (0)
- Differences in intention to use flavored oral nicotine products among young adult e-cigarette users and non-users (2022) (0)
- The Effect of Smoking Cues in Antismoking Public Service Announcements on Smoking Urge and Psychophysiological Reactions (2008) (0)
- RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and alleles (2015) (0)
- Erratum In: "Balancing Consideration of the Risks and Benefits of E-Cigarettes". (2022) (0)
- Validation of a paradigm for screening medications for nicotine dependence. (2007) (0)
- Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder. (2021) (0)
- Effect of hepatic nicotine metabolism on nicotinic acetylcholine receptor availability and craving (2014) (0)
- Psycho-Physiological Responses to Anti-Marijuana PSAs: Validating the Construct of Message Sensation Value (2006) (0)
- Nicotine withdrawal alters neural responses to psychosocial stress (2016) (0)
- Willingness to Use Commercial Nicotine Gums, Lozenges, and Gummies Among Nontobacco Using Adolescents in Southern California. (2022) (0)
- Predictive Model of Effective Antismoking Arguments Using Computerized Text Analysis: Personal, Textual Features, and Their Interaction (2010) (0)
- Different measures of varenicline adherence, nicotine metabolite ratio and smoking abstinence (2019) (0)
- About Quest ® and other potential harm-reducing products Lower Nicotine Cigarettes May Not Lower Harm (2006) (0)
- Short Communication Individual Differences in Nicotine Intake per Cigarette 1 (2003) (0)
- μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief (2012) (0)
- Nicotine metabolite ratio in plasma and urine by different analytical methods and laboratories: Implications for clinical implementation (2015) (0)
- ABSTRACTS FROM THE 20TH NORTH AMERICAN ISSX MEETING (2016) (0)
- Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes (2022) (0)
- Influence of CYP2A6 genetic variation, nicotine dependence severity, and treatment on smoking cessation success. (2023) (0)
- Self-Efficacy to Smoking Abstinence Scale (2014) (0)
- Perceived Ad Effectiveness Scale (2015) (0)
- Cancer Epidemiology, Biomarkers & Prevention and Cancer Prevention Research: Two Journals, a Common Goal (2008) (0)
- Medication Treatments for Nicotine Dependence (2006) (0)
- Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes (2012) (0)
- An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation (2013) (0)
- Erratum: Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation (Nicotine and Tobacco Research (2007) vol. 9 (8) (821-833)) (2007) (0)
- Intention to Engage in Healthy Lifestyle Behaviors Measure (2015) (0)
- Abstract PL01-06: Nicotine-dependence pharmacogenetics: Implications for personalized therapy (2010) (0)
- Predictive Models of Effective Anti-Smoking Arguments by Using Computerized Text Analysis: Personal, Textual Features and Their Interaction: (521582014-003) (2009) (0)
- Pharmacogenetics of nicotine addiction treatment (2011) (0)
- Examining the role of mitochondrial genetic variation in nicotine dependence (2022) (0)
- Association of abstinence-induced alterations in working memory function and COMT genotype in smokers (2013) (0)
- Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio (2016) (0)
- Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy (2023) (0)
- Pharmacogenetic Approaches to Nicotine Dependence Treatment (2008) (0)
This paper list is powered by the following services:
Other Resources About Caryn Lerman
What Schools Are Affiliated With Caryn Lerman?
Caryn Lerman is affiliated with the following schools:
